KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC.
Saved in:
| Title: | KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC. |
|---|---|
| Authors: | Tubita A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Fancelli S; Oncology Unit, Careggi University Hospital, Florence, Italy., Anela L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Petroni G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Caliman E; Oncology Unit, Careggi University Hospital, Florence, Italy., Mazzoni F; Oncology Unit, Careggi University Hospital, Florence, Italy., Scolari F; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Napolitano B; Oncology Unit, Careggi University Hospital, Florence, Italy., Menicacci B; Department of Health Sciences, University of Florence, Florence, Italy., Comin CE; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Voltolini L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pillozzi S; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Oncology Unit, Careggi University Hospital, Florence, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 10; Vol. 15, pp. 1654491. Date of Electronic Publication: 2025 Sep 10 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41001026 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tubita+A%22">Tubita A</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Fancelli+S%22">Fancelli S</searchLink>; Oncology Unit, Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Anela+L%22">Anela L</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Petroni+G%22">Petroni G</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Caliman+E%22">Caliman E</searchLink>; Oncology Unit, Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Mazzoni+F%22">Mazzoni F</searchLink>; Oncology Unit, Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Scolari+F%22">Scolari F</searchLink>; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Napolitano+B%22">Napolitano B</searchLink>; Oncology Unit, Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Menicacci+B%22">Menicacci B</searchLink>; Department of Health Sciences, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Comin+CE%22">Comin CE</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Voltolini+L%22">Voltolini L</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Pillozzi+S%22">Pillozzi S</searchLink>; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Antonuzzo+L%22">Antonuzzo L</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Oncology Unit, Careggi University Hospital, Florence, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Sep 10; Vol. 15, pp. 1654491. <i>Date of Electronic Publication: </i>2025 Sep 10 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41001026 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1654491 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1654491 Titles: – TitleFull: KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tubita A – PersonEntity: Name: NameFull: Fancelli S – PersonEntity: Name: NameFull: Anela L – PersonEntity: Name: NameFull: Petroni G – PersonEntity: Name: NameFull: Caliman E – PersonEntity: Name: NameFull: Mazzoni F – PersonEntity: Name: NameFull: Scolari F – PersonEntity: Name: NameFull: Napolitano B – PersonEntity: Name: NameFull: Menicacci B – PersonEntity: Name: NameFull: Comin CE – PersonEntity: Name: NameFull: Voltolini L – PersonEntity: Name: NameFull: Pillozzi S – PersonEntity: Name: NameFull: Antonuzzo L IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 09 Text: 2025 Sep 10 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |